GSK NEXT

gsk-next-logo

GSK NEXT is the strategic commercial growth engine for GSK Consumer Healthcare, focused on the creation and scaling of net-new product, service and platform businesses across everyday health.

#SimilarOrganizations #People #Financial #More

GSK NEXT

Status:
Active

Email Addresses:
[email protected]


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

Current Employees Featured

malcolm-fogarty_image

Malcolm Fogarty
Malcolm Fogarty Founder @ GSK NEXT
Founder
2020-05-01

Founder


malcolm-fogarty_image

Malcolm Fogarty

Investments List

Date Company Article Money raised
2021-11-16 Bristle GSK NEXT investment in Non Equity Assistance - Bristle N/A
2021-11-16 Patientory GSK NEXT investment in Seed Round - Patientory N/A
2021-11-16 Smilo.AI GSK NEXT investment in Non Equity Assistance - Smilo.AI N/A
2021-11-16 Health In Her HUE GSK NEXT investment in Non Equity Assistance - Health In Her HUE N/A
2021-11-16 nQ Medical GSK NEXT investment in Seed Round - nQ Medical N/A
2021-11-16 Unfabled GSK NEXT investment in Non Equity Assistance - Unfabled N/A

More informations about "GSK NEXT"

GSK NEXT - Crunchbase Investor Profile & Investments

GSK NEXT the disruptive innovation arm of the science-led global consumer healthcare company GSK. See details»

Home | GSK Canada

The homepage of the GSK Canada websiteA new era for human health Welcome to our Canadian website. GSK is a global biopharma company with the ambition โ€ฆ See details»

GSK revenue hole raises chances of risky M&A move | Reuters

22 hours ago CEO Emma Walmsleyโ€™s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance sheet may allow her to buy targets like obesity drug โ€ฆ See details»

New GSK to deliver step-change in growth and โ€ฆ

Jun 23, 2021 Over the next five-year period, New GSK expects to deliver sales growth and adjusted operating profit growth of more than 5% and more than 10%, โ€ฆ See details»

Canada leadership team - GSK

The Leadership Team encompasses the Country Executive Board (CEB) and is responsible for the management of the business See details»

Company | GSK

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together See details»

Purpose, strategy and culture | GSK Canada

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of โ€ฆ See details»

Meet GSK management

Cautionary statement regarding forward-looking statements This presentation may contain forward-looking statements. Forward-looking statements give the Groupโ€™s current expectations or โ€ฆ See details»

Company | GSK Canada

GSK has a history in Canada that dates back to 1902. We currently employ approximately 1,628 full time employees across the country, providing a salary โ€ฆ See details»

Innovation | GSK Canada

GSK Canada works actively with academic researchers, university industry liaison and technology transfer offices, and innovation hubs such as the Quebec โ€ฆ See details»

GSK breaks up with BIO for 2025

Nov 8, 2024 GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, โ€ฆ See details»

GSK Org Chart + Executive Team - The Official Board

The org chart of GSK contains its 207 main executives like Emma Walmsley, Julie Brown, Luke Miels and Adam Walker. See details»

New GSK to deliver step-change in growth and performance

Jun 25, 2021 GlaxoSmithKline has announced New GSK, which will deliver step-change in growth and performance over next ten years, driven by a high-quality Vaccines and Specialty Medicines โ€ฆ See details»

Purpose, strategy and culture - GSK

Our culture Culture at GSK is something we all own. It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. Our culture of being ambitious for โ€ฆ See details»

GSK's blood cancer drug fails to secure US FDA advisers' support

Jul 17, 2025 The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns about previously documented risks of eye โ€ฆ See details»

GSK > InContext Consultancy Group

GSK is one of the most prominent pharmaceutical companies worldwide. Among the many projects taken on by GSK, cross-functional teams tackle the entire lifecycle of new vaccine development: โ€ฆ See details»

GSK NEXT - Investments, Portfolio & Company Exits - Crunchbase

Jul 20, 2022 GSK NEXT the disruptive innovation arm of the science-led global consumer healthcare company GSK. See details»

Company | GSK US

We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally. Learn more about our views and our โ€ฆ See details»

GSK NEXT - Financial Details - Crunchbase

GSK NEXT has made 8 investments. Their most recent investment was on Jul 20, 2022, when Dianox raiseda new funding round. How many investments has this organization made over time? โ€ฆ See details»

GSK's blood cancer drug gets EU approval | Reuters

1 day ago The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood plasma cells, the British drugmaker said on Thursday. See details»

linkstock.net © 2022. All rights reserved